Thromb Haemost 1996; 75(04): 695-696
DOI: 10.1055/s-0038-1650347
Letter to the Editor
Schattauer GmbH Stuttgart

Frequency of Antibodies Directed against Heparin-Platelet Factor 4 in Patients Exposed to Heparin through Chronic Hemodialysis

M de Sancho
1   Dept. of Hematology, Mount Sinai Medical Center, New York, USA
,
M G Lema
1   Dept. of Hematology, Mount Sinai Medical Center, New York, USA
,
J Amiral
2   Serbio Laboratories, Gennevilliers, France
,
J Rand
1   Dept. of Hematology, Mount Sinai Medical Center, New York, USA
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 07. August 1995

Accepted after resubmission 10. Januar 1996

Publikationsdatum:
10. Juli 2018 (online)

 
  • References

  • 1 Warkentin T, Kelton J. Heparin-induced thrombocytopenia. Progr Haemostas Thrombosis 1991; 10: 1-34
  • 2 Amiral J, Bridey F, Dreyfus M, Vissac A, Fressinaud E, Wolf M, Meyer D. Platelet Factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992; 68: 95
  • 3 Gruel Y, Boizard-Boval B, Wautier JL. Further evidence that a granule components such as PF4 are involved in platelet-IgG heparin interactions during heparin-associated thrombocytopenia. Thromb Haemost 1993; 68: 374-375
  • 4 Amiral J, Bridey F, Dreyfus M, Vissac AM, Fressinaud E, Meyer D. Identification of PF4 as a target for antibodies generated in heparin induced thrombocytopenia. Development of a diagnostic test. Thromb Haemost 1991; 65: 865 (Abstract)